Chaz Langelier, MD, PhD
Associate Professor
Medicine
School of Medicine

The translational research in my lab bridges basic and clinical investigation by engaging genomic technologies to understand relationships between microbes, host response and clinical outcomes. We study lower respiratory tract infections, ARDS, sepsis, nosocomial infections, and emerging pathogens including SARS-CoV-2.

Show full bio (70 words) Hide full bio

One focus area involves developing new diagnostic techniques that combine metagenomic sequencing and machine learning to simultaneously profile both host and microbiome from clinical samples. A second focus area involves studying the host response to infections and identifying disease sub-phenotypes that correlate with outcomes. Genomic epidemiology is a third focus area, and our group carries out real-time assessment of hospital outbreaks and surveillance for emerging respiratory pathogens.

Education & Training

Show all (4) Hide

  • Clinical Fellowship Infectious Diseases University of California San Francisco 07/2016
  • Medical Residency Internal Medicine University of California San Francisco 06/2014
  • M.D., Ph.D. Medicine/Biochemistry University of Utah 05/2011
  • B.A. with honors, summa cum laude Chemistry/Biochemistry Colby College 05/2000

Interests

Show all (10) Hide

  • respiratory infections
  • emerging pathogens
  • air pollution and respiratory infections
  • smoking and respiratory infections
  • microbial diagnostics
  • next generation sequencing
  • infectious diseases
  • antibiotic resistance
  • antibiotic stewardship
  • global health

Publications (136)

Top publication keywords:
Staphylococcal InfectionsRespiratory Tract InfectionsBacteremiaNasopharynxCritical IllnessBacterial InfectionsDrug Resistance, BacterialSepsisPneumoniaRhizopusDrug Resistance, MicrobialRespiratory Syncytial Virus, HumanCross InfectionMicrobiotaMetagenomics

Show all (131 more) Hide